Swan Capital’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$582 Hold
115
﹤0.01% 406
2025
Q1
$608 Hold
115
﹤0.01% 316
2024
Q4
$777 Buy
+115
New +$777 ﹤0.01% 297